Generics

Midodrine hydrochloride tablets have a market value of roughly $59.9 million for the 12 months ended September 2020, according to IQVIA.

Camber's generic Accolate is available in dosage strengths of 10 mg and 20 mg.

Hikma's generic Vascepa provides a treatment to be used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia.

Rufinamide oral suspension had a market value of approximately $125 million in the 12 months ended September 2020, according to IQVIA.

Zydus Cadila's generic dapagliflozin tablets will be available in dosage strengths of 5 mg and 120 mg, pending FDA final approval.

Akorn's new board appointments follow the completion of the sale of Akorn on Oct. 1.

Former Bristol Myers Squibb executive Bill Szablewski will serve as head of capital markets for Viatris, the company being created by the merger of Mylan and Pfizer's Upjohn.

Levothyroxine sodium capsules had a market value of roughly $111 million for the 12 months ended September 2020, according to IQVIA, although actual generic market values are expected to be lower.